Is this new therapy for postnatal depression effective?
Zuranolone, a new drug for postnatal depression, improves on treatments available to date. It is taken for only 15 days and works from the first dose1
Zuranolone, a new drug for postnatal depression, improves on treatments available to date. It is taken for only 15 days and works from the first dose1
As one of its many initiatives, the Diabetes Unit is implementing a scorecard to segment patients with diabetes and offer more efficient treatment at1
Although it is not the only risk factor for schizophrenia, genetics is the most significant, contributing in 80% of cases.
That is the conclusion of a study evaluating all the clinical tools used for the early diagnosis of this disorder. This information makes it is easie1
A study published in the journal World Psychiatry has assessed the impact of mental disorders on physical diseases (such as heart attacks or cancer),1
Combining the data obtained from magnetic resonance imaging and the patient's clinical data could make it possible to estimate the relapse risk after1
Non-alcoholic or low-alcohol beverages can have a negative impact on people with an alcohol use disorder. This was suggested by a systematic review c1
Baby Blues can appear after childbirth. These are transitory feelings of sadness, nervousness, insecurity or worry. If these symptoms persist or wors1
The list, published by Clarivate Analytics, identifies the most influential experts, who are among the 1% most highly cited in their speciality in di1
On 3 November 2022, the TV3 Marató Foundation announced the research projects that will receive funding from the 2021 Marató, dedicated to mental dis1